Amedisys Inc (NQ: AMED )

97.67 -0.08 (-0.08%)

Streaming Delayed Price Updated: 12:07 PM EDT, Jul 24, 2024 Add to My Watchlist

Price and Volume

Volume	75,362
Open	97.52
Bid (Size)	97.63 (1)
Ask (Size)	97.70 (2)
Prev. Close	97.75
Today's Range	97.25 - 97.93
52wk Range	89.55 - 98.46
Shares Outstanding	32,631,959
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

AMED Stock Earnings: Amedisys Beats EPS, Beats Revenue for Q1 2024

April 24, 2024

AMED stock results show that Amedisys beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes

April 23, 2024

It's not just enough for a company to pay a dividend, investors should look for dividend growth stocks that can continue to pay.

Via InvestorPlace

Performance

YTD	+2.85%	+2.85%
1 Month	+6.57%	+6.57%
3 Month	+7.15%	+7.15%
6 Month	+3.09%	+3.09%
1 Year	+6.88%	+6.88%

More News

3 Stocks To Turn $1,000 Into $10,000 in 10 Years

January 12, 2024

Via InvestorPlace

3 Stocks Profiting from America’s Long-Term Care Crisis

November 22, 2023

Via InvestorPlace

Cantor Fitzgerald Maintains Neutral Rating for Amedisys: Here's What You Need To Know

September 14, 2023

Via Benzinga

Is NASDAQ:AMED suited for quality investing?

August 14, 2023

Via Chartmill

What 11 Analyst Ratings Have To Say About Amedisys

July 27, 2023

Via Benzinga

Analyst Ratings for Amedisys

June 27, 2023

Via Benzinga

Expert Ratings for Amedisys

June 06, 2023

Via Benzinga

The 3 Best Stock Picks for This Week

September 05, 2023

Via InvestorPlace

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EchoStar Corporation (Nasdaq - SATS), Sovos Brands, Inc. (Nasdaq - SOVO), Reata Pharmaceuticals, Inc. (Nasdaq - RETA), Amedisys, Inc. (Nasdaq – AMED)

August 08, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Reata Pharmaceuticals, Inc. (Nasdaq – RETA), Talaris Therapeutics, Inc. (Nasdaq – TALS), Inpixon® (Nasdaq – INPX), Amedisys, Inc. (Nasdaq – AMED)

July 28, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE – AEL), Amedisys, Inc. (Nasdaq – AMED), Sigilon Therapeutics, Inc (Nasdaq – SGTX)

July 25, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

July 20, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Is UnitedHealth Group Stock a Buy Now?

July 11, 2023

Via The Motley Fool

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Amedisys, Inc. (Nasdaq – AMED)

July 10, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Meta Platforms To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday

July 06, 2023

Via Benzinga

AMED Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amedisys, Inc. Is Fair to Shareholders

June 26, 2023

From Halper Sadeh LLC

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2023

July 06, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023

June 07, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2023

June 28, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2023

June 06, 2023

Via Benzinga

Optum's Decision To Target Amedisys Is Intriguing, Says Analyst

June 05, 2023

Via Benzinga

Why Shares Of Amedisys Inc Are Rising

June 05, 2023

Via Benzinga

Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session

June 05, 2023

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.